nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—smooth muscle tissue—esophageal cancer	0.0317	0.114	CbGeAlD
Bimatoprost—PTGFR—bronchus—esophageal cancer	0.0259	0.0932	CbGeAlD
Bimatoprost—PTGFR—smooth muscle tissue—esophageal cancer	0.0253	0.0912	CbGeAlD
Bimatoprost—PTGER3—digestive system—esophageal cancer	0.025	0.09	CbGeAlD
Bimatoprost—PTGFR—trachea—esophageal cancer	0.0232	0.0837	CbGeAlD
Bimatoprost—Iloprost—PDE4D—esophageal cancer	0.022	0.662	CrCbGaD
Bimatoprost—AKR1C3—bronchus—esophageal cancer	0.021	0.0757	CbGeAlD
Bimatoprost—PTGER3—lung—esophageal cancer	0.0209	0.0752	CbGeAlD
Bimatoprost—AKR1C3—smooth muscle tissue—esophageal cancer	0.0206	0.0741	CbGeAlD
Bimatoprost—AKR1C3—trachea—esophageal cancer	0.0189	0.068	CbGeAlD
Bimatoprost—PTGFR—lung—esophageal cancer	0.0167	0.0601	CbGeAlD
Bimatoprost—PTGER3—lymph node—esophageal cancer	0.0143	0.0514	CbGeAlD
Bimatoprost—AKR1C3—lung—esophageal cancer	0.0136	0.0488	CbGeAlD
Bimatoprost—PTGFR—lymph node—esophageal cancer	0.0114	0.0411	CbGeAlD
Bimatoprost—AKR1C3—lymph node—esophageal cancer	0.00927	0.0334	CbGeAlD
Bimatoprost—Punctate keratitis—Capecitabine—esophageal cancer	0.00841	0.0615	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—esophageal cancer	0.00667	0.201	CrCbGaD
Bimatoprost—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00553	0.0404	CcSEcCtD
Bimatoprost—Dinoprostone—CYP19A1—esophageal cancer	0.00456	0.137	CrCbGaD
Bimatoprost—Hirsutism—Capecitabine—esophageal cancer	0.00365	0.0267	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00357	0.0261	CcSEcCtD
Bimatoprost—Infection—Carboplatin—esophageal cancer	0.00348	0.0255	CcSEcCtD
Bimatoprost—Keratitis—Capecitabine—esophageal cancer	0.00327	0.0239	CcSEcCtD
Bimatoprost—Pain—Carboplatin—esophageal cancer	0.003	0.0219	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00266	0.0194	CcSEcCtD
Bimatoprost—Eye irritation—Capecitabine—esophageal cancer	0.00249	0.0182	CcSEcCtD
Bimatoprost—Skin discolouration—Capecitabine—esophageal cancer	0.00235	0.0172	CcSEcCtD
Bimatoprost—Lacrimation increased—Capecitabine—esophageal cancer	0.0023	0.0168	CcSEcCtD
Bimatoprost—Burning sensation—Methotrexate—esophageal cancer	0.00228	0.0166	CcSEcCtD
Bimatoprost—Cataract—Capecitabine—esophageal cancer	0.00223	0.0163	CcSEcCtD
Bimatoprost—Inflammation—Capecitabine—esophageal cancer	0.00219	0.016	CcSEcCtD
Bimatoprost—Dry eye—Capecitabine—esophageal cancer	0.00196	0.0143	CcSEcCtD
Bimatoprost—Nasopharyngitis—Cisplatin—esophageal cancer	0.00187	0.0137	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—esophageal cancer	0.00175	0.0128	CcSEcCtD
Bimatoprost—Eye pain—Capecitabine—esophageal cancer	0.00171	0.0125	CcSEcCtD
Bimatoprost—Inflammation—Methotrexate—esophageal cancer	0.00163	0.0119	CcSEcCtD
Bimatoprost—Arthritis—Capecitabine—esophageal cancer	0.00159	0.0116	CcSEcCtD
Bimatoprost—Cystitis noninfective—Methotrexate—esophageal cancer	0.00154	0.0113	CcSEcCtD
Bimatoprost—Diplopia—Capecitabine—esophageal cancer	0.00154	0.0113	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—esophageal cancer	0.00153	0.0112	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—esophageal cancer	0.00143	0.0104	CcSEcCtD
Bimatoprost—Liver function test abnormal—Capecitabine—esophageal cancer	0.00142	0.0104	CcSEcCtD
Bimatoprost—Connective tissue disorder—Cisplatin—esophageal cancer	0.00142	0.0104	CcSEcCtD
Bimatoprost—Dry skin—Capecitabine—esophageal cancer	0.00141	0.0103	CcSEcCtD
Bimatoprost—Visual impairment—Cisplatin—esophageal cancer	0.00139	0.0102	CcSEcCtD
Bimatoprost—Nasopharyngitis—Capecitabine—esophageal cancer	0.00138	0.0101	CcSEcCtD
Bimatoprost—Eye disorder—Cisplatin—esophageal cancer	0.00135	0.00988	CcSEcCtD
Bimatoprost—Asthma—Capecitabine—esophageal cancer	0.00133	0.00974	CcSEcCtD
Bimatoprost—Mediastinal disorder—Cisplatin—esophageal cancer	0.0013	0.00953	CcSEcCtD
Bimatoprost—Bronchitis—Capecitabine—esophageal cancer	0.00128	0.00937	CcSEcCtD
Bimatoprost—Erythema—Cisplatin—esophageal cancer	0.00126	0.00921	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00124	0.00905	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—esophageal cancer	0.00121	0.00885	CcSEcCtD
Bimatoprost—Vision blurred—Cisplatin—esophageal cancer	0.00119	0.00868	CcSEcCtD
Bimatoprost—Depression—Capecitabine—esophageal cancer	0.00118	0.00866	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—PDE4D—esophageal cancer	0.0011	0.002	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKAP13—esophageal cancer	0.00109	0.00198	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KMT2D—esophageal cancer	0.00109	0.00197	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CSNK1A1—esophageal cancer	0.00109	0.00196	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CSNK1A1—esophageal cancer	0.00108	0.00195	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GNG7—esophageal cancer	0.00107	0.00194	CbGpPWpGaD
Bimatoprost—Rhinitis—Capecitabine—esophageal cancer	0.00107	0.00782	CcSEcCtD
Bimatoprost—Anxiety—Cisplatin—esophageal cancer	0.00107	0.00781	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—ANXA1—esophageal cancer	0.00107	0.00193	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00106	0.00778	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—esophageal cancer	0.00106	0.00775	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CA2—esophageal cancer	0.00106	0.00192	CbGpPWpGaD
Bimatoprost—Pharyngitis—Capecitabine—esophageal cancer	0.00106	0.00774	CcSEcCtD
Bimatoprost—Oedema peripheral—Capecitabine—esophageal cancer	0.00105	0.00768	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—GNG7—esophageal cancer	0.00105	0.0019	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Capecitabine—esophageal cancer	0.00105	0.00766	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—SST—esophageal cancer	0.00104	0.00188	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00104	0.00187	CbGpPWpGaD
Bimatoprost—Visual impairment—Capecitabine—esophageal cancer	0.00103	0.00751	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—ADCYAP1—esophageal cancer	0.00103	0.00186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PDE4D—esophageal cancer	0.00102	0.00185	CbGpPWpGaD
Bimatoprost—Infection—Cisplatin—esophageal cancer	0.00102	0.00747	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—GHRL—esophageal cancer	0.00101	0.00183	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Cisplatin—esophageal cancer	0.00101	0.00737	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PFN1—esophageal cancer	0.00101	0.00182	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADCYAP1—esophageal cancer	0.001	0.00182	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PDE4D—esophageal cancer	0.001	0.00181	CbGpPWpGaD
Bimatoprost—Skin disorder—Cisplatin—esophageal cancer	0.000998	0.0073	CcSEcCtD
Bimatoprost—Eye disorder—Capecitabine—esophageal cancer	0.000997	0.00729	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—esophageal cancer	0.000992	0.00725	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—ADH7—esophageal cancer	0.000985	0.00178	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PLCE1—esophageal cancer	0.000985	0.00178	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000973	0.00176	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GNG7—esophageal cancer	0.000973	0.00176	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADCYAP1—esophageal cancer	0.000968	0.00175	CbGpPWpGaD
Bimatoprost—Angiopathy—Capecitabine—esophageal cancer	0.000968	0.00707	CcSEcCtD
Bimatoprost—Mediastinal disorder—Capecitabine—esophageal cancer	0.000961	0.00703	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—GNG7—esophageal cancer	0.000952	0.00172	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL2—esophageal cancer	0.000944	0.00171	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—WWOX—esophageal cancer	0.000938	0.0017	CbGpPWpGaD
Bimatoprost—Erythema—Capecitabine—esophageal cancer	0.000928	0.00679	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000924	0.00167	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000922	0.00674	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—WWOX—esophageal cancer	0.000918	0.00166	CbGpPWpGaD
Bimatoprost—Dyspnoea—Cisplatin—esophageal cancer	0.000916	0.0067	CcSEcCtD
Bimatoprost—AKR1C3—Disease—ELMO1—esophageal cancer	0.000912	0.00165	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ELMO1—esophageal cancer	0.000904	0.00164	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FKBP1A—esophageal cancer	0.000892	0.00161	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GSTO1—esophageal cancer	0.000891	0.00161	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TPI1—esophageal cancer	0.000891	0.00161	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000887	0.00649	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—WWOX—esophageal cancer	0.000886	0.0016	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKAP13—esophageal cancer	0.000884	0.0016	CbGpPWpGaD
Bimatoprost—Depression—Methotrexate—esophageal cancer	0.000882	0.00645	CcSEcCtD
Bimatoprost—Pain—Cisplatin—esophageal cancer	0.000879	0.00643	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—ANXA1—esophageal cancer	0.000878	0.00159	CbGpPWpGaD
Bimatoprost—Vision blurred—Capecitabine—esophageal cancer	0.000875	0.0064	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—FKBP1A—esophageal cancer	0.000873	0.00158	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—WIF1—esophageal cancer	0.000872	0.00158	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ADH1B—esophageal cancer	0.000863	0.00156	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000859	0.00156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL2—esophageal cancer	0.000857	0.00155	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ALDOB—esophageal cancer	0.000854	0.00155	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—SST—esophageal cancer	0.000854	0.00155	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—WIF1—esophageal cancer	0.000853	0.00154	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FKBP1A—esophageal cancer	0.000842	0.00152	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL2—esophageal cancer	0.000839	0.00152	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—SST—esophageal cancer	0.000836	0.00151	CbGpPWpGaD
Bimatoprost—Vertigo—Capecitabine—esophageal cancer	0.000834	0.0061	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—GHRL—esophageal cancer	0.000832	0.00151	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TYMP—esophageal cancer	0.000825	0.00149	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—WIF1—esophageal cancer	0.000823	0.00149	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HIST1H2BM—esophageal cancer	0.000822	0.00149	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GAPDH—esophageal cancer	0.000822	0.00149	CbGpPWpGaD
Bimatoprost—Palpitations—Capecitabine—esophageal cancer	0.00082	0.006	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000815	0.00148	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GHRL—esophageal cancer	0.000814	0.00147	CbGpPWpGaD
Bimatoprost—Cough—Capecitabine—esophageal cancer	0.00081	0.00592	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PDE4D—esophageal cancer	0.000808	0.00146	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CSNK1A1—esophageal cancer	0.000805	0.00146	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP26A1—esophageal cancer	0.000803	0.00145	CbGpPWpGaD
Bimatoprost—Hypertension—Capecitabine—esophageal cancer	0.000802	0.00586	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—ANXA1—esophageal cancer	0.000797	0.00144	CbGpPWpGaD
Bimatoprost—Chest pain—Capecitabine—esophageal cancer	0.00079	0.00578	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—esophageal cancer	0.000788	0.00576	CcSEcCtD
Bimatoprost—Anxiety—Capecitabine—esophageal cancer	0.000788	0.00576	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000788	0.00143	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000785	0.00574	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—ALOX15—esophageal cancer	0.000782	0.00142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ANXA1—esophageal cancer	0.00078	0.00141	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—SST—esophageal cancer	0.000775	0.0014	CbGpPWpGaD
Bimatoprost—Dry mouth—Capecitabine—esophageal cancer	0.000773	0.00565	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—GNG7—esophageal cancer	0.000769	0.00139	CbGpPWpGaD
Bimatoprost—Visual impairment—Methotrexate—esophageal cancer	0.000765	0.00559	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000763	0.00138	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CSNK1A1—esophageal cancer	0.00076	0.00138	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—SST—esophageal cancer	0.000759	0.00137	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GHRL—esophageal cancer	0.000755	0.00137	CbGpPWpGaD
Bimatoprost—Infection—Capecitabine—esophageal cancer	0.000753	0.0055	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—PFN1—esophageal cancer	0.000753	0.00136	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000747	0.00135	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTO1—esophageal cancer	0.000746	0.00135	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TPI1—esophageal cancer	0.000746	0.00135	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Capecitabine—esophageal cancer	0.000743	0.00543	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—esophageal cancer	0.000742	0.00542	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.00074	0.00134	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GHRL—esophageal cancer	0.000739	0.00134	CbGpPWpGaD
Bimatoprost—Asthenia—Cisplatin—esophageal cancer	0.000737	0.00539	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—PFN1—esophageal cancer	0.000737	0.00133	CbGpPWpGaD
Bimatoprost—Skin disorder—Capecitabine—esophageal cancer	0.000736	0.00538	CcSEcCtD
Bimatoprost—AKR1C3—Disease—XIAP—esophageal cancer	0.000726	0.00131	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000725	0.00131	CbGpPWpGaD
Bimatoprost—Angiopathy—Methotrexate—esophageal cancer	0.00072	0.00527	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—XIAP—esophageal cancer	0.00072	0.0013	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Methotrexate—esophageal cancer	0.000715	0.00523	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—ALDOB—esophageal cancer	0.000715	0.0013	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PFN1—esophageal cancer	0.000711	0.00129	CbGpPWpGaD
Bimatoprost—Erythema—Methotrexate—esophageal cancer	0.000691	0.00505	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GAPDH—esophageal cancer	0.000689	0.00125	CbGpPWpGaD
Bimatoprost—Insomnia—Capecitabine—esophageal cancer	0.000685	0.00501	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CRABP1—esophageal cancer	0.000682	0.00124	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNA1—esophageal cancer	0.000681	0.00123	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL2—esophageal cancer	0.000677	0.00123	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ELMO1—esophageal cancer	0.000676	0.00122	CbGpPWpGaD
Bimatoprost—Dyspnoea—Capecitabine—esophageal cancer	0.000675	0.00494	CcSEcCtD
Bimatoprost—AKR1C3—Disease—B2M—esophageal cancer	0.000675	0.00122	CbGpPWpGaD
Bimatoprost—Dyspepsia—Capecitabine—esophageal cancer	0.000667	0.00488	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000662	0.0012	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ELMO1—esophageal cancer	0.000662	0.0012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKAP13—esophageal cancer	0.000661	0.0012	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000654	0.00478	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—esophageal cancer	0.000651	0.00476	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GNG7—esophageal cancer	0.000649	0.00118	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000648	0.00117	CbGpPWpGaD
Bimatoprost—Rash—Cisplatin—esophageal cancer	0.000648	0.00474	CcSEcCtD
Bimatoprost—Pain—Capecitabine—esophageal cancer	0.000648	0.00474	CcSEcCtD
Bimatoprost—Dermatitis—Cisplatin—esophageal cancer	0.000647	0.00473	CcSEcCtD
Bimatoprost—AKR1C3—Disease—ENO1—esophageal cancer	0.000647	0.00117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKAP13—esophageal cancer	0.000647	0.00117	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ELMO1—esophageal cancer	0.000638	0.00116	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSME2—esophageal cancer	0.000638	0.00115	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSME1—esophageal cancer	0.000638	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSME2—esophageal cancer	0.000633	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSME1—esophageal cancer	0.000633	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ANXA1—esophageal cancer	0.00063	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKAP13—esophageal cancer	0.000624	0.00113	CbGpPWpGaD
Bimatoprost—Vertigo—Methotrexate—esophageal cancer	0.000621	0.00454	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—SST—esophageal cancer	0.000612	0.00111	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CALR—esophageal cancer	0.000612	0.00111	CbGpPWpGaD
Bimatoprost—Nausea—Cisplatin—esophageal cancer	0.000611	0.00446	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00061	0.0011	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALDH2—esophageal cancer	0.000608	0.0011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDE4D—esophageal cancer	0.000604	0.00109	CbGpPWpGaD
Bimatoprost—Cough—Methotrexate—esophageal cancer	0.000603	0.00441	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—GHRL—esophageal cancer	0.000597	0.00108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000597	0.00108	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH3—esophageal cancer	0.000597	0.00108	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FBXW7—esophageal cancer	0.000592	0.00107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDE4D—esophageal cancer	0.000591	0.00107	CbGpPWpGaD
Bimatoprost—Chest pain—Methotrexate—esophageal cancer	0.000588	0.0043	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—FBXW7—esophageal cancer	0.000587	0.00106	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000584	0.00427	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GSTT1—esophageal cancer	0.000579	0.00105	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000576	0.00104	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNG7—esophageal cancer	0.000575	0.00104	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP2A6—esophageal cancer	0.000572	0.00104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDE4D—esophageal cancer	0.000571	0.00103	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00057	0.00103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNG7—esophageal cancer	0.000563	0.00102	CbGpPWpGaD
Bimatoprost—Infection—Methotrexate—esophageal cancer	0.00056	0.0041	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—esophageal cancer	0.000553	0.00404	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—esophageal cancer	0.000548	0.00401	CcSEcCtD
Bimatoprost—Asthenia—Capecitabine—esophageal cancer	0.000544	0.00397	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—GNG7—esophageal cancer	0.000543	0.000983	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS1—esophageal cancer	0.000542	0.000982	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ENO1—esophageal cancer	0.000542	0.000982	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—XIAP—esophageal cancer	0.000539	0.000975	CbGpPWpGaD
Bimatoprost—Pruritus—Capecitabine—esophageal cancer	0.000536	0.00392	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH2—esophageal cancer	0.000535	0.000969	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PSME1—esophageal cancer	0.000534	0.000967	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PSME2—esophageal cancer	0.000534	0.000967	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—XIAP—esophageal cancer	0.000527	0.000954	CbGpPWpGaD
Bimatoprost—Insomnia—Methotrexate—esophageal cancer	0.00051	0.00373	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CTNNA1—esophageal cancer	0.000509	0.000922	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—XIAP—esophageal cancer	0.000509	0.000921	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL2—esophageal cancer	0.000506	0.000917	CbGpPWpGaD
Bimatoprost—Dyspnoea—Methotrexate—esophageal cancer	0.000503	0.00368	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—esophageal cancer	0.000501	0.00367	CcSEcCtD
Bimatoprost—Dizziness—Capecitabine—esophageal cancer	0.000501	0.00366	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CTNNA1—esophageal cancer	0.000499	0.000903	CbGpPWpGaD
Bimatoprost—Dyspepsia—Methotrexate—esophageal cancer	0.000496	0.00363	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CXCL2—esophageal cancer	0.000496	0.000897	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000487	0.00356	CcSEcCtD
Bimatoprost—Pain—Methotrexate—esophageal cancer	0.000482	0.00353	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNA1—esophageal cancer	0.000481	0.000871	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFBR2—esophageal cancer	0.000479	0.000867	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL2—esophageal cancer	0.000478	0.000866	CbGpPWpGaD
Bimatoprost—Rash—Capecitabine—esophageal cancer	0.000478	0.00349	CcSEcCtD
Bimatoprost—Dermatitis—Capecitabine—esophageal cancer	0.000477	0.00349	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—TGFBR2—esophageal cancer	0.000475	0.00086	CbGpPWpGaD
Bimatoprost—Headache—Capecitabine—esophageal cancer	0.000475	0.00347	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—PSME2—esophageal cancer	0.000473	0.000856	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PSME1—esophageal cancer	0.000473	0.000856	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ANXA1—esophageal cancer	0.000471	0.000852	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000467	0.000845	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSME2—esophageal cancer	0.000463	0.000838	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSME1—esophageal cancer	0.000463	0.000838	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1B1—esophageal cancer	0.000461	0.000835	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ANXA1—esophageal cancer	0.000461	0.000834	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SST—esophageal cancer	0.000458	0.000829	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SMAD4—esophageal cancer	0.000453	0.000821	CbGpPWpGaD
Bimatoprost—Nausea—Capecitabine—esophageal cancer	0.00045	0.00329	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—SMAD4—esophageal cancer	0.00045	0.000814	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SST—esophageal cancer	0.000448	0.000812	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSME2—esophageal cancer	0.000447	0.000809	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSME1—esophageal cancer	0.000447	0.000809	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GHRL—esophageal cancer	0.000446	0.000808	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH3—esophageal cancer	0.000446	0.000808	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ANXA1—esophageal cancer	0.000445	0.000805	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FBXW7—esophageal cancer	0.000439	0.000795	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH3—esophageal cancer	0.000437	0.000791	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GHRL—esophageal cancer	0.000437	0.000791	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP19A1—esophageal cancer	0.000433	0.000785	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SST—esophageal cancer	0.000432	0.000783	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FBXW7—esophageal cancer	0.00043	0.000778	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GHRL—esophageal cancer	0.000421	0.000763	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH3—esophageal cancer	0.000421	0.000763	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FBXW7—esophageal cancer	0.000415	0.000751	CbGpPWpGaD
Bimatoprost—Asthenia—Methotrexate—esophageal cancer	0.000405	0.00296	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH2—esophageal cancer	0.0004	0.000725	CbGpPWpGaD
Bimatoprost—Pruritus—Methotrexate—esophageal cancer	0.000399	0.00292	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—HMOX1—esophageal cancer	0.000396	0.000716	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH2—esophageal cancer	0.000392	0.000709	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000388	0.000702	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ABCB1—esophageal cancer	0.00038	0.000687	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH2—esophageal cancer	0.000378	0.000684	CbGpPWpGaD
Bimatoprost—Dizziness—Methotrexate—esophageal cancer	0.000373	0.00273	CcSEcCtD
Bimatoprost—AKR1C3—Disease—HIF1A—esophageal cancer	0.000371	0.000671	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HIF1A—esophageal cancer	0.000368	0.000666	CbGpPWpGaD
Bimatoprost—Rash—Methotrexate—esophageal cancer	0.000356	0.0026	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—esophageal cancer	0.000355	0.0026	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—TGFBR2—esophageal cancer	0.000355	0.000643	CbGpPWpGaD
Bimatoprost—Headache—Methotrexate—esophageal cancer	0.000353	0.00258	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—KDR—esophageal cancer	0.000352	0.000637	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFBR2—esophageal cancer	0.000348	0.000629	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS2—esophageal cancer	0.000337	0.000611	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SMAD4—esophageal cancer	0.000336	0.000609	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFBR2—esophageal cancer	0.000335	0.000607	CbGpPWpGaD
Bimatoprost—Nausea—Methotrexate—esophageal cancer	0.000335	0.00245	CcSEcCtD
Bimatoprost—AKR1C3—Disease—NOTCH1—esophageal cancer	0.000334	0.000605	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH1—esophageal cancer	0.000331	0.0006	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SMAD4—esophageal cancer	0.000329	0.000596	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SMAD4—esophageal cancer	0.000317	0.000575	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CREBBP—esophageal cancer	0.000303	0.000548	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CREBBP—esophageal cancer	0.0003	0.000544	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—esophageal cancer	0.000295	0.000534	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000287	0.00052	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000282	0.000511	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—esophageal cancer	0.000275	0.000498	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—esophageal cancer	0.000271	0.000491	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—esophageal cancer	0.000269	0.000487	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—esophageal cancer	0.000269	0.000487	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—esophageal cancer	0.000263	0.000476	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—esophageal cancer	0.00026	0.00047	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—esophageal cancer	0.000257	0.000466	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—esophageal cancer	0.000256	0.000464	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CREBBP—esophageal cancer	0.000254	0.000459	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—esophageal cancer	0.000254	0.000459	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—esophageal cancer	0.000252	0.000455	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—esophageal cancer	0.000248	0.00045	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—esophageal cancer	0.000248	0.000449	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH1—esophageal cancer	0.000248	0.000449	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH1—esophageal cancer	0.000243	0.000439	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH1—esophageal cancer	0.000234	0.000424	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—esophageal cancer	0.000227	0.000411	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CREBBP—esophageal cancer	0.000225	0.000407	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—esophageal cancer	0.000222	0.000402	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—esophageal cancer	0.000221	0.0004	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CREBBP—esophageal cancer	0.00022	0.000398	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1A—esophageal cancer	0.000217	0.000393	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—esophageal cancer	0.000216	0.000391	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1A—esophageal cancer	0.000215	0.000389	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CREBBP—esophageal cancer	0.000212	0.000384	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000211	0.000382	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—esophageal cancer	0.000208	0.000376	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000207	0.000374	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EP300—esophageal cancer	0.000206	0.000374	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EP300—esophageal cancer	0.000205	0.00037	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—esophageal cancer	0.000201	0.000364	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—esophageal cancer	0.000197	0.000356	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—esophageal cancer	0.000192	0.000347	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—esophageal cancer	0.00019	0.000344	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—esophageal cancer	0.000188	0.000341	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000188	0.00034	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—esophageal cancer	0.000184	0.000333	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—esophageal cancer	0.00018	0.000326	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—esophageal cancer	0.000178	0.000323	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—esophageal cancer	0.000178	0.000322	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—esophageal cancer	0.000176	0.000318	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—esophageal cancer	0.000174	0.000316	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—EP300—esophageal cancer	0.000173	0.000313	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—esophageal cancer	0.000166	0.000301	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—esophageal cancer	0.000163	0.000295	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1A—esophageal cancer	0.000161	0.000291	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1A—esophageal cancer	0.000157	0.000285	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—esophageal cancer	0.000157	0.000284	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EP300—esophageal cancer	0.000153	0.000277	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—esophageal cancer	0.000153	0.000276	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1A—esophageal cancer	0.000152	0.000275	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—esophageal cancer	0.000151	0.000274	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EP300—esophageal cancer	0.00015	0.000271	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—esophageal cancer	0.000146	0.000265	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EP300—esophageal cancer	0.000144	0.000262	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—esophageal cancer	0.000133	0.000241	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—esophageal cancer	0.000131	0.000236	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—esophageal cancer	0.00013	0.000236	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—esophageal cancer	0.000128	0.000231	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—esophageal cancer	0.000128	0.000231	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—esophageal cancer	0.000126	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—esophageal cancer	0.000123	0.000223	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—esophageal cancer	0.000113	0.000205	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—esophageal cancer	0.000111	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—esophageal cancer	0.000109	0.000198	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—esophageal cancer	0.000107	0.000194	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—esophageal cancer	0.000107	0.000194	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—esophageal cancer	0.000103	0.000187	CbGpPWpGaD
